Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study (2019) Goebell P, Hermann E, Kube U, Doehn C, Marschner N, Dietel A, Blumenstengel K, et al. Journal article Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options (2019) Ahrens M, Scheich S, Hartmann A, Bergmann L Journal article, Review article Barriers to using a nationwide skin cancer screening program: Findings from Germany (2018) Goerig T, Schneider S, Schilling L, Diehl K Journal article Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study (2018) Schochter F, Rack B, Tzschaschel M, Polasik A, Andergassen U, Trapp E, Alunni-Fabbroni M, et al. Journal article Reliability of determining the resectability of locally progressed pancreatic ductal adenocarcinomas - results from the CONKO-007 multicenter randomized controlled trial (EudraCT:2009-014476-21) (2018) Wittel UA, Golcher H, Gruetzmann R, Bechstein WO, Belyaev O, Uhl W, Ghadimi M, et al. Conference contribution Radiosensitizing and radioprotecting effect of kinase-inhibitor Palbociclib in different normal tissue and cancer cell lines (2018) Jost T, Hecht M, Fietkau R, Distel L Conference contribution Pathologic complete response after induction therapy and surgery is an independed long-term survival prognostic factor in locally advanced non-small cell lung cancer (2018) Schreiner W, Dudek W, Lettmaier S, Rieker R, Fietkau R, Sirbu H Conference contribution Inflammatory cells infiltrating HPV positive and negative head and neck squamous cell carcinoma (2018) Distel L, Farhoumand D, Haderlein M, Fietkau R Conference contribution Effect of the kinase-inhibitor Palbociclib on radio-therapeutic treatment in a 3D cell culture model (2018) Jost T, Hecht M, Fietkau R, Distel L Conference contribution Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use (2018) Cao J, Wiesweg M, Fuchs M, Stein A, Karthaus M, Lettmaier S, Kretzschmar A, et al. Conference contribution